ICFO has now used the LUCA platform to characterize the thyroid tissue with simultaneous anatomical measurements, the first ...

Viridian Therapeutics, Inc.'s stock soars on positive trial results, analysts bullish on FDA approval in 2026. Read more on ...

The company’s chronic thyroid eye disease treatment, veligrotug, was able to reduce eye bulge by 56% compared with placebo.